Silvant Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-759
| Closed | -$118K | – | 334 |
|
|
2021
Q2 | $118K | Hold |
759
| – | – | 0.02% | 220 |
|
|
2021
Q1 | $120K | Hold |
759
| – | – | 0.02% | 219 |
|
|
2020
Q4 | $176K | Hold |
759
| – | – | 0.03% | 193 |
|
|
2020
Q3 | $166K | Buy |
759
+521
| +219% | +$114K | 0.03% | 187 |
|
|
2020
Q2 | $68K | Buy |
+238
| New | +$68K | 0.01% | 238 |
|